Granite Point Capital Management, L.P. Care Dx, Inc. Transaction History

Granite Point Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$57.62 - $95.6 $8.07 Million - $13.4 Million	-140,000 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$41.43 - $77.09 $3.31 Million - $6.17 Million	80,000 Added 133.33%	140,000 $10.1 Million
Q3 2020 Nov 06, 2020	BUY	$30.88 - $37.94 $617,600 - $758,800	20,000 Added 50.0%	60,000 $2.28 Million
Q1 2020 May 12, 2020	SELL	$13.94 - $28.25 $1.04 Million - $2.11 Million	-74,722 Reduced 65.13%	40,000 $873,000
Q4 2019 Feb 10, 2020	BUY	$19.24 - $28.41 $1.03 Million - $1.52 Million	53,562 Added 87.58%	114,722 $2.48 Million
Q2 2018 Aug 13, 2018	SELL	$7.93 - $15.79 $740,186 - $1.47 Million	-93,340 Reduced 60.41%	61,160 $749,000
Q1 2018 May 15, 2018	SELL	$5.18 - $7.97 $183,890 - $282,935	-35,500 Reduced 18.68%	154,500 $1.23 Million
Q4 2017 Feb 08, 2018	BUY	$3.98 - $7.37 $756,200 - $1.4 Million	190,000	190,000 $1.4 Million

201

54.8M

85K

33.1K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $802M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.